Other
Transcranial Magnetic Stimulation
0
Pipeline Programs↗
3
Active Trials↗
2
Companies Involved↗
Transcranial Magnetic Stimulation is an early-stage landscape with 0 programs across 2 companies. The most active players are Neurocrine Biosciences, Xenon Pharmaceuticals Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
17
clinical trials
Completed9 · 53%
Unknown status4 · 24%
Not yet recruiting2 · 12%
Withdrawn1 · 6%
Recruiting1 · 6%
Clinical Trials
Trial Activity
17 trials
Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation
Recruiting·—·Phase 2/3·NCT06201897·40 enrolled
Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression
Completed·—·N/A·NCT06325605·100 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)